Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Fortress Biotech, Inc. (FBIO)

NASDAQ

$2.72

$+0.01

(+0.37%)

Previous Close: ⁦$2.71⁩

Market Closed

Fortress Biotech, Inc. (FBIO) Live Price Chart

Last updated: ⁦2026-09-06 08:32:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Fortress Biotech, Inc. (FBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.72, with a market capitalisation of $91.05M and a P/E ratio of 0.87. Over the past 52 weeks, its price has ranged from $2.18 to $4.53. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$91.05M
Open	$2.68
Day's High	$91.50
Day's Low	$1.24
Previous Close	$2.71
Volume	159.03K
Average Volume	--
P/E Ratio	0.87
52-Week High	$4.53
52-Week Low	$2.18
Dividend Yield	0.37%
Earnings Date	--

Fortress Biotech, Inc. (FBIO) Latest Closing Stock Price

Fortress Biotech, Inc. (FBIO) last closed at $2.71 as of 2026-09-04 23:57:00, unchanged from the previous close of $2.71.

During the latest regular trading session, FBIO traded between $1.24 and $91.50, with a volume of 159.03K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Fortress Biotech, Inc. (FBIO) 7-Day Stock Price Change

Over the past seven days, Fortress Biotech, Inc. (FBIO) moved from $2.80 to $2.72, representing a decline of 2.72% ($0.08).

The stock traded between $2.68 and $2.79 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 328.76 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

FBIO 52-Week Price Position

Position in Range: 22.9%

52W Low$2.18

52W High$4.53

FBIO is currently trading at $2.72, placing it 22.9% of the way from its 52-week low of $2.18 to its 52-week high of $4.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Fortress Biotech, Inc. (FBIO)?

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Fortress Biotech, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	78
Exchange	NASDAQ
Company Website	https://www.fortressbiotech.com

How to Buy Fortress Biotech, Inc. (FBIO) Stock on MEXC

Eligible investors can buy real shares of Fortress Biotech, Inc. (FBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FBIO and Place Your Order

Open the RealStocks trading page and search for FBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Fortress Biotech, Inc. (FBIO) share price today?

Fortress Biotech, Inc. (FBIO) is currently trading at $ 2.72, up 0.33% ($0.01) from the previous close of $ 2.71. Intraday prices update in real time during regular trading hours.

2.Is FBIO stock going up or down today?

As of 2026-09-04 23:57:00, FBIO is trading at $ 2.72, up 0.33% ($0.01) from its previous close of $ 2.71. The stock has traded between $ 1.24 and $ 91.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is FBIO pre-market price?

As of 2026-09-04 23:57:00, FBIO is trading at $ 2.75 in pre-market trading, up 1.55% ($0.04) from the previous close of $ 2.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FBIO after-hours price?

As of 2026-09-04 23:57:00, FBIO is trading at $ 2.76 in after-hours trading, up 1.73% ($0.05) from the regular-session close of $ 2.71. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is FBIO stock trading now?

FBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FBIO sit relative to its 52-week high and low?

Over the past 52 weeks, FBIO has traded between a low of $ 2.18 and a high of $ 4.53. At $ 2.72, the stock is positioned 22.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Fortress Biotech, Inc. in?

Fortress Biotech, Inc. (FBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Fortress Biotech, Inc.'s market capitalisation and where is it listed?

Fortress Biotech, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 91.05M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FBIO valued in terms of P/E ratio and EPS?

FBIO trades at a P/E ratio of 0.87, based on trailing-twelve-month EPS of $ 3.10. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Fortress Biotech, Inc. pay a dividend?

Fortress Biotech, Inc. pays an indicated annual cash dividend of $ 0.01 per share, with a current dividend yield of 0.37% based on the latest share price. Dividend policies are subject to change at the board's discretion.